Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Study of Thymus Transplantation in DiGeorge Anomaly, IND 9836, #932.1

NCT00576836 is registered in ClinicalTrials.gov with Sumitomo Pharma Switzerland GmbH as lead sponsor.

NCT NCT00576836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00576836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Study of Thymus Transplantation in DiGeorge Anomaly, IND 9836, #932.1
Lead sponsor
Sumitomo Pharma Switzerland GmbH
Phase
Phase 2
Overall status
Completed
Start date
September 2, 2004
Completion date
December 31, 2019
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complete digeorge anomaly, complete digeorge syndrome, digeorge anomaly, digeorge syndrome